Interestingly, individuals with T2DM were not administered medications known to influence the HOMA-IR index, such as sulfonylurea derivatives or glucagon-like peptide-1 receptor agonists (GLP-1 insulin analogs). The gene discussed is INS; the disease is type 2 diabetes mellitus.